Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study-Reference-Cited by-同舟云学术

Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study

Published:2022-08-18 Issue:6 Volume:9 Page:4291-4297
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Iso Takashi¹,Matsue Yuya¹^ORCID,Mizukami Akira²,Tokano Takashi³,Isoda Kikuo⁴,Suwa Satoru⁵,Miyauchi Katsumi⁶,Yanagisawa Naotake⁷,Okumura Yasuo⁸,Minamino Tohru¹⁹

Affiliation:

1. Department of Cardiovascular Biology and Medicine Juntendo University Graduate School of Medicine Tokyo Japan

2. Department of Cardiology Kameda Medical Center Kamogawa Japan

3. Department of Cardiology Juntendo University Urayasu Hospital Urayasu Japan

4. Department of Cardiology Juntendo University Nerima Hospital Tokyo Japan

5. Department of Acute Critical Care Medicine, Shizuoka Hospital Juntendo University Tokyo Japan

6. Department of Cardiovascular Medicine Juntendo Tokyo Koto Geriatric Medical Center Tokyo Japan

7. Medical Technology Innovation Center Juntendo University Tokyo Japan

8. Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan

9. Japan Agency for Medical Research and Development‐Core Research for Evolutionary Medical Science and Technology (AMED‐CREST), Japan Agency for Medical Research and Development Tokyo Japan

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14109

Reference38 articles.

1. Anemia in Heart Failure

2. Prognostic Impact of Anemia in Patients With Chronic Heart Failure　– With Special Reference to Clinical Background: Report From the CHART-2 Study –

3. Association between anemia, clinical features and outcome in patients hospitalized for acute heart failure syndromes

4. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

5. Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparison of the Clinical Characteristics of Short-, Mid-, and Long-Term Mortality in Patients Attended by the Emergency Medical Services: An Observational Study;Diagnostics;2024-06-19

2. A Prospective Randomized Controlled Clinical Study to Investigate the Efficacy and Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia Switched from Continuous Erythropoietin Receptor Activator Treatment;Journal of Clinical Medicine;2024-05-08

3. An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease;Reviews in Cardiovascular Medicine;2024-04-11

4. AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte;The Heart Surgery Forum;2024-01-14

5. Contributions of anemia to exercise intolerance in heart failure with preserved ejection fraction–An exercise stress echocardiographic study;IJC Heart & Vasculature;2023-10